Michael Downes
50Patents
7h-index
46Co-inventors
72Inventor score
Filing activity: Mar 10, 2000 → Jul 19, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8999929B2 | Fibroblast growth factor 1 protein fragments and methods of use | Chemistry; Metallurgy | 56 | Active |
| US9072708B2 | Methods for treating metabolic disorders using FGF | Human Necessities | 19 | Active |
| US8906854B2 | Methods for treating metabolic disorders using FGF | Human Necessities | 19 | Active |
| US6673587B1 | Histone deacetylase, and uses therefor | Chemistry; Metallurgy | 13 | Expired |
| US9938234B2 | PPAR agonists | Chemistry; Metallurgy | 12 | Active |
| US10035819B2 | PPAR agonists and methods of use thereof | Chemistry; Metallurgy | 11 | Active |
| US9446097B2 | Methods for treating metabolic disorders using FGF | Human Necessities | 8 | Active |
| US10077268B2 | FXR agonists and methods for making and using | Chemistry; Metallurgy | 7 | Active |
| US10399958B2 | PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof | Chemistry; Metallurgy | 6 | Active |
| US9546379B2 | Compositions and methods for treating type 1 and type 2 diabetes and related disorders | Chemistry; Metallurgy | 6 | Active |
| US8212006B2 | Structure of the farnesoid X receptor ligand binding domain and methods of use therefor | Physics | 6 | Active |
| US10479775B1 | PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof | Chemistry; Metallurgy | 6 | Active |
| US9808508B2 | Methods for treating metabolic disorders using FGF | Human Necessities | 5 | Active |
| US9925243B2 | Chimeric fibroblast growth factor (FGF) 2/FGF1 peptides and methods of use | Chemistry; Metallurgy | 5 | Active |
| US9925241B2 | Mutated fibroblast growth factor (FGF) 1 and methods of use | Chemistry; Metallurgy | 5 | Active |
| US8318708B2 | Use of vitamin D receptor agonists, ligands, and precursors to treat pancreatic fibrosis | Physics | 4 | Active |
| US10912800B2 | Compositions and methods for treating type 1 and type 2 diabetes and related disorders | Chemistry; Metallurgy | 4 | Active |
| US7671085B2 | Non-steroidal farnesoid X receptor modulators and methods for the use thereof | Chemistry; Metallurgy | 4 | Expired |
| US10920199B2 | Reprogramming progenitor compositions and methods of use therefore | Chemistry; Metallurgy | 4 | Active |
| US10293027B2 | Methods for treating metabolic disorders using FGF | Human Necessities | 2 | Active |
| US10301268B2 | Analogs of fexaramine and methods of making and using | Chemistry; Metallurgy | 2 | Active |
| US9895381B2 | Vitamin D receptor agonists to treat diseases involving CXCL12 activity | Human Necessities | 2 | Active |
| US9872866B2 | Vitamin D receptor/SMAD genomic circuit gates fibrotic response | Physics | 2 | Active |
| US10159711B2 | Methods for treating metabolic disorders using FGF | Human Necessities | 2 | Active |
| US9192601B2 | Methods for enhancing muscle performance and tone | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.